- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05690100
Evaluation of the Use of Ozone Gel Versus Hyaluronic Acid Gel on Palatal Wound Healing .
Clinical Evaluation of the Use of Ozone Gel Versus Hyaluronic Acid Gel on Palatal Wound After Free Gingival Graft Harvesting: A Randomized Controlled Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hisham T Ahmed
- Phone Number: +201119993768
- Email: Hisham.mahmoud@dentistry.cu.edu.eg
Study Contact Backup
- Name: Nesma M Shemais
- Email: nesma.shemais@dentistry.cu.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with mucogingival defects scheduled for free gingival graft
- Systemically healthy
Exclusion Criteria:
- Smokers
- Occlusal trauma at site of graft
- Pregnancy and lactation
- Patients allergic to the used agents
- Severe gagging reflex
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ozone Gel
Ozone is a potent oxidant with marked antimicrobial activity and the potential to act as a metabolic and host immune modulator.The routes of ozone administration are topical and regional for both gaseous and aqueous forms .Ozone gel is contains ozonated extra virgin olive oil and Arnica montana extract, containing essential fatty acids Ozone gel was claimed to have analgesic (Tasxdemir et al,2016) and anti-inflammatory effect its high content of essential fatty acids and the effect of ozone, natural extra virgin olive oil (I.
Lezcano,et al.2000).
Ozone gel has a beneficial role in wound healing, Its wound healing properties may be due to enhancing blood circulation and immune response.(M.colombo et,al 2019), Generic name : GeliO3 Dosage form : Gel Frequency/Duration : Once on this interval : 0,3,7,14
|
Anti-inflammatory Gel which has a beneficial role on wound healing
|
|
Experimental: Hyaluronic Acid 0.2%
HA was Known for hygroscopicity that allows it to maintain conformational stiffness and to retain water.(Yıldırım et al., 2017b) .Another major feature is viscoelasticity that provides stability and elasticity to tissues and delays penetration of viruses and bacteria (Finn, Schow and Schneiderman, 1992) . In periodontology, HA has been advocated as monotherapy(Hammad et al., 2011) or as an adjunct to non-surgical and/or surgical (Fawzy El-Sayed et al., 2012) periodontal treatment to reduce inflammation and promote wound healing. HA gel was used in two different concentrations 0.2% and 0.8% versus negative control in the management of post-operative pain after FGG surgery and it was found effective with more superior results for the 0.2% concentration (Yıldırım et al., 2017b). Generic name : GingiGel Dosage form : Gel Frequency/Duration : Once on this interval : 0,3,7,14 |
Anti-inflammatory Gel which has a beneficial role on wound healing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post Operative Pain
Time Frame: 14 days
|
Post operative pain measured directly through VAS score with 0 means no pain and 10 means the maximum pain or indirectly by analgesics consumption by the patient
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound Size
Time Frame: 42 days
|
Wound size decrease/closure
|
42 days
|
|
Color Match
Time Frame: 42 days
|
the color of the palatal mucosa will be assessed by comparing it with that of the adjacent and opposite side by using the objective VAS (VAS score 0-10) represented by a continuous line, by a clinician blinded to the treatment group assignment. A score of 0 indicates no color match, and a score of 10 indicates excellent color match with the adjacent tissues. |
42 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ahmed M barbari, Cairo university
- Study Chair: Dalia M Ghalwash, Cairo university
- Study Chair: Nesma M Shemais, Cairo university
- Principal Investigator: Hisham Ahmed, Cairo university
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OZVHA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Palate; Wound
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingInsulin | Wound Healing | Palate; WoundBrazil
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
The University of Texas Health Science Center at...CompletedPalatal Donor Site Wound Healing Following Periodontal Plastic Surgery Using Amnion-Chorion MembranePalate; WoundUnited States
-
Ataturk UniversityCompletedPalate; Wound | Wound Healing DisorderTurkey
-
University of Roma La SapienzaActive, not recruitingWound Healing | Palate; Wound | Hyaluronic AcidItaly
-
Beirut Arab UniversityRecruiting
-
Cairo UniversityRecruiting
-
Universitat Internacional de CatalunyaCompleted
-
Izmir Katip Celebi UniversityCompleted
-
Krishnadevaraya College of Dental Sciences & HospitalCompleted
Clinical Trials on GeliO3
-
Cairo UniversityRecruitingPeriodontal DiseasesEgypt